By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ArQule, Inc. 

19 Presidential Way

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-994-0300 Fax: 781-376-6019



Drug Discovery




Daiichi Sankyo, Inc. 

Company News
ArQule, Inc. (ARQL) To Report Second Quarter 2015 Financial Results On August 5, 2015 7/29/2015 10:52:41 AM
ArQule, Inc. (ARQL) Announces Interim Phase II Study Results For Tivantinib In Combination With Cetuximab In Patients With MET-High, KRAS Wild Type Colorectal Cancer Presented At ESMO World Congress On Gastrointestinal Cancer 2015 7/6/2015 7:42:31 AM
ArQule, Inc. (ARQL) Appoints Robert J. Weiskopf As Chief Financial Officer 6/1/2015 1:46:37 PM
ASCO15: ArQule, Inc. (ARQL) Announces Data Presentations With Tivantinib And ARQ 087 To Be Featured At ASCO 2015 6/1/2015 1:35:45 PM
ArQule, Inc. (ARQL) To Present At Jefferies and Co. 2015 Global Healthcare Conference 5/28/2015 10:46:24 AM
ArQule, Inc. (ARQL) Reports First Quarter 2015 Financial Results 5/6/2015 12:10:28 PM
ArQule, Inc. (ARQL) And Beryllium Announce Collaborative Research And Development Agreement 5/5/2015 8:51:07 AM
ArQule, Inc. (ARQL) To Report First Quarter 2015 Financial Results On May 6, 2015 4/29/2015 12:30:15 PM
ArQule, Inc. (ARQL) Announces Data Presentations With ARQ 087, Inhibitor Of FGFR, At AACR 4/21/2015 11:22:44 AM
ArQule, Inc. (ARQL) To Present at 14th Annual Needham Healthcare Conference 4/7/2015 10:54:30 AM